Corticosteroid Administration in COPD: Summary of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines 2017
Subhabrata Moitra PDF Share this article
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Subhabrata Moitra PDF Share this article
Chronic respiratory disease which majorly includes Asthma and Chronic Obstructive pulmonary disease that may account for an estimated burden of about 100 million individuals in India. There were only ... objective of…
very substantial manner to reduce the tolerance to exercise in a patient with chronic obstructive pulmonary disease. Methods: this was an exhaustive research on benefits of exercise training
Background and objective: The British Thoracic Society (BTS) recommends that sedation for
Background: Pulmonary arterial hypertension is frequent in patients with severe chronic obstructive pulmonary disease (COPD). It increases the morbidity and mortality of patients with advanced stage of COPD
Introduction: Chronic obstructive pulmonary disease is one of the main causes of morbidity, mortality, and health-care costs entire the world. During acute exacerbations, whether or not with a history
identify the factors influencing health-related quality of life (HRQOL) of patients with chronic obstructive pulmonary disease (COPD). Methods: A sample of 108 Patients diagnosed with COPD was recruited from
useful marker of disease progression and its relationship with other disease outcomes in chronic obstructive pulmonary disease patients
During the combination treatment of chronic obstructive pulmonary disease in association with ischemic heart disease, the increasing attention is paid to pleiotropic effects of statins. Inclusion of rosuvastatin
little data about effect of (VAP) on outcome among patients with acute exacerbation of chronic obstructive pulmonary disease. Materials & Methods: A prospective study included patients with COPD exacerbation requiring…
Bronchopulmonary Dysplasia (BPD) is the most common respiratory disorder that affects chronically preterms with immature lungs. On this base it seems extremely pressing to investigate the consequences of BPD also…
Introduction: Anxiety and depression are underdiagnosed in Chronic Obstructive Pulmonary Disease (COPD) patients. Few studies have tried to identify their association with hospitalization (severe exacerbation). The…
Chronic Obstructive Pulmonary Disease (COPD), inhaled particles and gases trigger an inflammatory response, favoring tissue proliferation in small airways and tissue destruction in lung parenchyma, in addition to the…
Chronic Obstructive Pulmonary Disease (COPD) is one of the major causes of increased morbidity and mortality in the world and it is characterized by persistent progressive airflow limitation accompanied
Introduction: Chronic obstructive pulmonary disease is a common condition, characterized by a persistent blockage of airflow, partially reversible and progressive, that represents 5% of the total deaths around the world…
population. Objective: To find out the frequency of depression in patients with chronic obstructive pulmonary disease. Materials & Methods: 100 consecutive patients with diagnosed COPD (on history, physical examination…
Chronic Obstructive Pulmonary Disease (COPD) is an important contributor to mortality and morbidity in developed countries but there is limited data from Africa. Apart from tobacco smoking, household air pollution
COPD is the fourth leading cause of death worldwide and some speculate
BACKGROUND The drop in oxygen saturation during sleep is more than during
Chronic obstructive pulmonary disease (COPD) is a devastating lung disorder characterized by sustained airway flow restriction that is not fully reversible. The precise pathogenic mechanisms are unknown ... clear that…
Purpose: Chronic obstructive pulmonary disease (COPD) is a multicomponent disease. There is a need for biological markers for better evaluation of patients with COPD. We tested the hypothesis that elevated
Witte S, Bredenbroker D, Bethke TD. Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 366 (9485), 563–571 (2005) [1]. Chronic obstructive
For authors and organisers
Find the right journal for your paper and submit your manuscript.